stocktools
Offerings // Ping An Biomedical Co., Ltd.

PASW offering history

Every offering-related filing in Ping An Biomedical Co., Ltd.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 102 filings back to Dec 21, 2021.

Last executed offering
Jul 21, 2025
424B4 — priced deal (shares or notes)
Last registration (announced)
Feb 13, 2026
F-1 — capacity, not a sale
Executed, last 12 months
0
424B pricings + 8-K 3.02 sales
Registered, last 12 months
1
S-1/S-3/F-series registrations
DateFilingWhat it means
Feb 26, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 13, 2026F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Jul 21, 2025424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jul 21, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jul 11, 2025FWP →MARKETINGFree-writing prospectus — offering being marketed
Jun 30, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 26, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Apr 14, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Mar 25, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Mar 18, 2025FWP →MARKETINGFree-writing prospectus — offering being marketed
Mar 17, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Jan 24, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Nov 4, 2024F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Oct 23, 2024F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Oct 4, 2024RW →WITHDRAWNRegistration withdrawn
Oct 4, 2024F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Jun 28, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 18, 2024F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Feb 20, 2024FWP →MARKETINGFree-writing prospectus — offering being marketed
Jan 10, 2024F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Nov 16, 2023F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Oct 31, 2023F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Oct 20, 2023F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Sep 18, 2023F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
May 16, 2023F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Apr 28, 2023F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
PASW offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full PASW workspace →
PASW offering FAQ

When did PASW last execute an offering?

Per SEC filings, Ping An Biomedical Co., Ltd.'s most recent priced offering document is a 424B4 filed 2025-07-21. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did PASW last announce or register an offering?

The most recent registration is a F-1 filed 2026-02-13. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.